Home > Journals > The Journal of Cardiovascular Surgery > Past Issues > The Journal of Cardiovascular Surgery 2000 October;41(5) > The Journal of Cardiovascular Surgery 2000 October;41(5):781-4

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Share

 

CASE REPORTS  THORACIC PAPERS 

The Journal of Cardiovascular Surgery 2000 October;41(5):781-4

Copyright © 2009 EDIZIONI MINERVA MEDICA

language: English

Huge malignant localized fibrous tumor of the pleura

Veronesi G., Spaggiari L., Mazzarol G. *, De Pas M. **, Leo F., Solli P., Pastorino U.

From the Department of Thoracic Surgery *Department of Pathology **Division of Medical Oncology European Institute of Oncology, Milan, Italy


PDF


Local­ized ­fibrous ­tumor is an unfre­quent mesen­chymal neo­plasm. The malig­nant var­iant of the ­pleura is excep­tional and dif­fe­ren­tial diag­nosis ­with the ­more fre­quent ­benign ­type or ­with ­other neo­plasms ­such as ­soft ­tissue sar­coma and mesoth­e­lioma is ­rarely pos­sible in a pre­op­er­a­tive set­ting. The ­best treat­ment of ­this dis­ease is rad­ical sur­gical resec­tion. No defin­i­tive ­data ­exist ­about the ­role of chem­o­therapy. We ­report a ­case of a ­giant ­right intra­tho­racic ­mass ­whose pre­op­er­a­tive diag­nosis, ­from an ­open ­biopsy, was con­sis­tent ­with sar­coma and, in a ­second ­review, ­with ­fibrous ­tumor of the ­pleura ­without any indi­ca­tion ­about malig­nancy. A ­right pleu­rop­neu­mo­nec­tomy and per­i­car­dial resec­tion was per­formed ­through a ­right hem­i­clam­shell ­approach. His­tology dem­on­strated an aggres­sive beha­viour: ­high ­mitosis ­rate, Ki 67 of 34% and dif­fuse ­necrosis ­were ­present. In con­sid­er­a­tion of the ­apparent ­local radi­cality we ­did not per­form any adju­vant treat­ment. Six ­months ­after the oper­a­tion a ­wide ­local recur­rence was evi­dent and a ­systemic treat­ment ­with Ifos­fa­mide and Adri­am­i­cina is ­still in ­progress. So far a ­good ­response has ­been doc­u­mented. Pre­op­er­a­tive diag­nosis of malig­nancy has an impor­tant ­role as a ther­a­peutic ­strategy in man­age­ment of ­fibrous ­tumours of the ­pleura. ­When ­there is sus­pi­cion of a malig­nant ­form neo­ad­ju­vant chem­o­therapy can rep­re­sent a fur­ther ­tool to con­trol ­poorly dif­fer­en­tiated and ­large ­tumors, and a ­wide sur­gical resec­tion of the ­lesion ­must be per­formed.

top of page